兽医化学分析仪市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球兽医化学分析仪市场价值为 18 亿美元，预计 2025 年至 2034 年的复合年增长率为 9.4%。宠物拥有量的增加和诊断技术的进步是这一增长的主要驱动力。随着越来越多的家庭饲养宠物，对高效医疗保健和诊断解决方案的需求也激增。诊断技术极大地提高了兽医实践的准确性和效率。便携式分析仪在兽医诊所和研究实验室中越来越受欢迎，它可以进行快速的现场测试并最大限度地减少对实验室诊断的需求。人们对动物健康的认识不断提高以及政府对兽医诊断服务的支持增加进一步推动了市场扩张。

兽医化学分析仪分析动物的血液、血清、尿液和其他生物样本，提供对疾病诊断、治疗监测和动物健康管理至关重要的快速生化和电解质结果。市场依类型分为便携式分析仪和台式分析仪。便携式市场在 2021 年的价值为 7.836 亿美元，到 2022 年将成长至 8.475 亿美元，到 2023 年将成长至 9.182 亿美元。即时诊断的日益普及推动了对便携式分析仪的需求，便携式分析仪提供紧凑且用户友好的解决方案，可快速提供结果。微流体和生物感测器的进步以及对牲畜健康监测日益增长的需求促进了这些设备的采用。

市场根据产品进一步划分为仪器和消耗品。耗材部分在 2024 年占据了 80.9% 的市场份额，包括兽医诊断所需的试剂、试纸和麵板。面板部分分为预装单滑块试剂面板和重新装入多滑块试剂面板。宠物医疗保健支出的增加以及宠物和牲畜数量的增加增加了对消耗品的需求，因为频繁的测试需要不断补充。消耗品采购的重复性确保了製造商的稳定收入。

根据动物类型，市场包括伴侣动物和牲畜。伴侣动物细分市场（包括狗、猫、马和其他动物）在 2024 年占据了市场主导地位，预计到 2034 年将达到 29 亿美元。对预防性护理（包括定期检查和诊断测试）的日益关注正在推动对分析仪的需求。宠物中糖尿病和肾臟疾病等慢性病的流行进一步促进了市场的成长。便携式和桌上型分析仪可进行即时血液和电解质测试，增强疾病监测和治疗。

市场按应用细分为血液化学分析、血气及电解质分析、尿液分析、血糖监测等。血液化学分析仍占主导地位，2024 年价值为 6.573 亿美元。这些分析仪可以评估血糖值、肾功能指标、肝臟酵素和电解质，有助于诊断和治疗监测。兽医领域的投资正在推动需求，以改进具有整合软体用于高通量分析的自动化分析仪。

根据最终用途，市场包括兽医实验室、兽医医院和诊所以及其他最终用户。兽医实验室领域在 2024 年的价值为 7.934 亿美元，由于对准确和快速诊断测试的需求不断增长而占据主导地位。对伴侣动物和牲畜进行大量样本处理使得兽医实验室采用自动化和台式分析仪。

2024 年，北美占最大的市场份额，为 39.1%，美国市场价值 2021 年为 5.051 亿美元，2022 年为 5.469 亿美元，2023 年为 5.932 亿美元。宠物拥有量的增加和对先进诊断解决方案的需求不断增长推动了市场成长。研发投入和主要行业参与者的存在促进了创新兽医化学分析仪的发展，进一步刺激了该地区的需求。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 宠物收养率上升，兽医保健支出增加
    • 技术进步提高了诊断的准确性和自动化程度
    • 动物疾病和人畜共通感染的盛行率不断上升
  • 产业陷阱与挑战
    • 兽医化学分析仪成本高昂
• 成长潜力分析
• 监管格局
• 技术格局
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按类型，2021 - 2034 年

• 主要趋势
• 便携的
• 桌上型

第六章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 仪器
  • 化学分析仪
  • 尿液分析仪
  • 血糖仪
  • 血液气体和电解质分析仪
• 耗材
  • 面板
    • 预装多种试剂面板
    • 预装单玻片试剂板
  • 测试条
  • 试剂

第七章：市场估计与预测：按动物类型，2021 - 2034 年

• 主要趋势
• 伴侣动物
  • 狗
  • 猫
  • 马匹
  • 其他伴侣动物
• 牲畜
  • 牛
  • 猪
  • 绵羊和山羊
  • 家禽

第八章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 血液化学分析
• 尿液分析
• 血气和电解质分析
• 血糖监测
• 其他应用

第九章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 兽医实验室
• 兽医医院和诊所
• 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• Bioevopeak
• Chengdu Seamaty Technology
• DiaSys Diagnostic Systems
• Eurolyser Diagnostica (Affiliate of Mars)
• Heska Corporation
• HORIBA Medical
• IDEXX Laboratories
• Randox Laboratories
• Shenzhen Mindray Animal Medical Technology
• SKYLA
• URIT Medical Electronic
• Zoetis

The Global Veterinary Chemistry Analyzer Market was valued at USD 1.8 billion in 2024 and is projected to grow at a CAGR of 9.4% from 2025 to 2034. Increasing pet ownership and advances in diagnostic technologies are the primary drivers of this growth. As households increasingly adopt pets, the demand for efficient healthcare and diagnostic solutions has surged. Diagnostic technologies have greatly improved accuracy and efficiency in veterinary practices. Portable analyzers, gaining popularity in veterinary clinics and research laboratories, allow rapid on-site testing and minimize the need for laboratory diagnostics. Growing awareness of animal health and increased government support for veterinary diagnostic services are further propelling market expansion.

Veterinary chemistry analyzers analyze blood, serum, urine, and other biological samples in animals, delivering rapid biochemical and electrolyte results essential for disease diagnosis, treatment monitoring, and animal health management. The market is segmented by type into portable and benchtop analyzers. The portable segment, valued at USD 783.6 million in 2021, grew to USD 847.5 million in 2022 and USD 918.2 million in 2023. The rising adoption of point-of-care diagnostics has driven the demand for portable analyzers, offering compact and user-friendly solutions that provide rapid results. Advances in microfluidics and biosensors and the growing need for livestock health monitoring contribute to the increasing adoption of these devices.

The market is further divided by product into instruments and consumables. The consumables segment, which accounted for 80.9% of the market in 2024, includes reagents, test strips, and panels required for veterinary diagnostics. The panels segment is bifurcated into preloaded single-slide reagent panels and reloaded multiple reagent panels. Rising pet healthcare expenditures and a growing population of pets and livestock have boosted the demand for consumables, as frequent testing necessitates continuous refills. The repetitive nature of consumables purchases ensures consistent revenue for manufacturers.

By animal type, the market includes companion animals and livestock animals. The companion animals segment, divided into dogs, cats, horses, and others, dominated the market in 2024 and is expected to reach USD 2.9 billion by 2034. Increasing focus on preventive care, including regular checkups and diagnostic testing, is driving demand for analyzers. The prevalence of chronic conditions like diabetes and kidney diseases in pets further boosts market growth. Portable and benchtop analyzers facilitate real-time blood and electrolyte testing, enhancing disease monitoring and treatment.

The market is segmented by application into blood chemistry analysis, blood gas and electrolyte analysis, urinalysis, glucose monitoring, and others. Blood chemistry analysis, valued at USD 657.3 million in 2024, remains the dominant segment. These analyzers assess blood glucose levels, kidney function markers, liver enzymes, and electrolytes, aiding in diagnosis and treatment monitoring. Investment in the veterinary sector to improve automated analyzers with integrated software for high-throughput analysis is driving demand.

By end use, the market includes veterinary laboratories, veterinary hospitals and clinics, and other end users. The veterinary laboratories segment, valued at USD 793.4 million in 2024, dominates due to the rising demand for accurate and rapid diagnostic testing. High-volume sample processing for companion and livestock animals has led veterinary laboratories to adopt both automated and benchtop analyzers.

North America held the largest market share of 39.1% in 2024, with the US market valued at USD 505.1 million in 2021, USD 546.9 million in 2022, and USD 593.2 million in 2023. Increasing pet ownership and rising demand for advanced diagnostic solutions have driven market growth. Investment in R&D and the presence of major industry players have led to the development of innovative veterinary chemistry analyzers, further fueling demand in the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet adoption and increasing veterinary healthcare expenditure
    • 3.2.1.2 Technological advancements lead to improved diagnostic accuracy and automation
    • 3.2.1.3 Increasing prevalence of animal diseases and zoonotic infections
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with veterinary chemistry analyzers
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Portable
• 5.3 Benchtop

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Instruments
  • 6.2.1 Chemistry analyzers
  • 6.2.2 Urine analyzers
  • 6.2.3 Glucometers
  • 6.2.4 Blood gas and electrolyte analyzers
• 6.3 Consumables
  • 6.3.1 Panels
    • 6.3.1.1 Preloaded multiple reagent panels
    • 6.3.1.2 Preloaded single-slide reagent panels
  • 6.3.2 Test strips
  • 6.3.3 Reagents

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Companion animals
  • 7.2.1 Dogs
  • 7.2.2 Cats
  • 7.2.3 Horses
  • 7.2.4 Other companion animals
• 7.3 Livestock animals
  • 7.3.1 Cattle
  • 7.3.2 Pigs
  • 7.3.3 Sheep and goats
  • 7.3.4 Poultry

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Blood chemistry analysis
• 8.3 Urinalysis
• 8.4 Blood gas and electrolyte analysis
• 8.5 Glucose monitoring
• 8.6 Other applications

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Veterinary laboratories
• 9.3 Veterinary hospitals and clinics
• 9.4 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Bioevopeak
• 11.2 Chengdu Seamaty Technology
• 11.3 DiaSys Diagnostic Systems
• 11.4 Eurolyser Diagnostica (Affiliate of Mars)
• 11.5 Heska Corporation
• 11.6 HORIBA Medical
• 11.7 IDEXX Laboratories
• 11.8 Randox Laboratories
• 11.9 Shenzhen Mindray Animal Medical Technology
• 11.10 SKYLA
• 11.11 URIT Medical Electronic
• 11.12 Zoetis